HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 442329Generated: October 30, 2026
4,5-Dihydrodiazepam → HCID 21414257, compound
https://huagongshe.com/reaction/442329
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4,5-Dihydrodiazepam | HCID 3081984 | — |
| Reactant | Magnesium monoxide | HCID 6850729 | — |
| Reactant | HCID 20486168 | HCID 20486168 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 21414257 | HCID 21414257 | 66.2% |
Reaction Steps
1 g. of 1-methyl-5-phenyl-7-chloro-1,3,4,5-tetrahydro-2H-1,4-benzodiazepine-2-one and 1 g. of magnesium oxide are added to a solution of 0.8 g. (2.29 mmoles) of 1-methyl-4-chlorocarbonyl-5-phenyl-7-chloro-1,3,4,5-tetrahydro-2H-1,4-benzodiazepine-2-one in 10 ml. of chloroform, and the mixture is stirred at 40° C. overnight. Thereafter the inorganic salts are filtered off, washed with 10 ml. of chloroform, and the chloroform solution is stirred with 10 ml. of 2n hydrochloric acid. The hydrochloride of the non-reacted base separates. The salt is filtered off, and the filtrate is washed with 5 ml. of 2.5 % aqueous sodium hydrocarbonate solution and with water. The chloroform solution is dried and evaporated. The obtained dry residue is recrystallized from ethanol. 0.91 g. (66.2 %) of di-(1-methyl-2-oxo-5-phenyl-7-chloro-1,3,4,5-tetrahydro-2H-1,4-benzodiazepine-4-yl)-ketone are obtained; m.p.: 263°-266° C., Rf2 = 0.71.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04045433 |
|---|
| Source dataset | uspto-grants-1977_08 |
|---|
| ORD ID | ord-41489eb5f57e4013b0436f20521b4b3c |
|---|
| Source note | uspto-grants-1977_08 |
|---|